New Logo July 12, 2022.png
Odyssey Health, Inc. Makes Statement Regarding its Concussion Drug Development Program
September 30, 2022 18:28 ET | Odyssey Health, Inc
Las Vegas Nevada, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., (the “Company” “Odyssey”) a company focused on developing a unique...
New Logo July 12, 2022.png
Odyssey Health, Inc. Announces Successful Completion of Phase I Clinical Trial for Concussion Drug
September 28, 2022 08:30 ET | Odyssey Health, Inc
Las Vegas, Nevada, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical...
Cambridge Isotope Laboratories
Cambridge Isotope Laboratories, Inc. (CIL) Partners With ISOtopic Solutions to Release the New Stable Isotope-Labeled and Unlabeled Crude Lipid Yeast Extracts
September 26, 2022 15:16 ET | Cambridge Isotope Laboratories
TEWKSBURY, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Cambridge Isotope Laboratories, Inc. (CIL) has partnered with ISOtopic Solutions to release the new stable isotope-labeled and unlabeled Crude...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Pharmaceuticals Announces Results of Phase 2 Study of Lasofoxifene vs. Fulvestrant in Postmenopausal Women With Locally Advanced or Metastatic ER+/HER2- Breast Cancer and an ESR1 Mutation
September 13, 2022 09:00 ET | Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...
22157.jpg
Japan Biotech Startups Directory 2022: Establishment, Technology, Patents, R&D Projects, Investors, Capital Policy, Management Team
September 05, 2022 07:53 ET | Research and Markets
Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The "The Directory of Biotech Startups in Japan 2021-2022" directory has been added to ResearchAndMarkets.com's offering. This report is a directory of...
Global Glycomics Market
Glycomics Global Market to Reach $3.22 Billion by 2028
September 02, 2022 08:33 ET | Research and Markets
Dublin, Sept. 02, 2022 (GLOBE NEWSWIRE) -- The "Glycomics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product; Application; End User and Geography" report has been added to ...
Isracann BioSciences Logo RGB@4x-100 LG.jpg
Isracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory Board
August 23, 2022 09:00 ET | Isracann Biosciences Inc.
VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted organization with a natural health...
New Logo July 12, 2022.png
Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial
August 18, 2022 08:00 ET | Odyssey Health, Inc
Las Vegas, NV, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,...
ibn-iw-globe-2.png
IBN (InvestorBrandNetwork) Announces ‘Dr. Finance Live’ Interview with NFL Hall of Famer Brett Favre and Odyssey Health Inc.’s Dr. Jacob VanLandingham
August 16, 2022 08:00 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 16, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – IBN, a multifaceted financial news and publishing company for private and public entities, today announces that NFL Hall of Famer...
MAKO Medical Launches ASPT Accredited Phlebotomy Program
MAKO Medical Launches ASPT Accredited Phlebotomy Program
August 15, 2022 17:23 ET | MAKO Medical
RALEIGH, N.C., Aug. 15, 2022 (GLOBE NEWSWIRE) -- MAKO Medical Laboratories, a national full service reference laboratory and national leader in COVID-19 testing, today announced the company’s...